Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
9 Results for ''
Translation News
Cantex licenses intellectual property from Harvard University to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
February 23, 2022
Press Release
Cystic fibrosis faithfully modeled in a human Lung Airway Chip
November 19, 2021
Press Release
Predicting influenza virus evolution in a human Lung Airway Chip
September 20, 2021
Press Release
Repurposing approved drugs for COVID-19 at an accelerated pace
June 16, 2020
Awards
Wyss Institute Receives Grant from Cystic Fibrosis Foundation
October 17, 2018
Press Release
Lung cancer research gets a breath of fresh air
October 10, 2017
Press Release
Pulmonary Thrombosis-on-a-Chip provides new avenue for drug development
May 22, 2017
Press Release
Modeling COPD and asthma in a human small airway-on-a-chip
December 21, 2015
Press Release
Airway muscle-on-a-chip mimics asthma
September 23, 2014
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
